Stage
DivestitureTotal Raised
$16.74MInvestors Count
9Deal Terms
2Portfolio Exits
2Lab21 Funding, Lab21 Valuation & Lab21 Revenue
8 Fundings
Lab21's latest funding round was a Acquired for on June 5, 2014.
Lab21's valuation in August 2010 was $30M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/5/2014 | Acquired | 1 | ||||
7/9/2012 | Growth Equity | |||||
2/20/2012 | Series A | |||||
8/17/2010 | Angel - II | $30M | ||||
9/7/2009 | Seed |
Date | 6/5/2014 | 7/9/2012 | 2/20/2012 | 8/17/2010 | 9/7/2009 |
|---|---|---|---|---|---|
Round | Acquired | Growth Equity | Series A | Angel - II | Seed |
Amount | |||||
Investors | |||||
Valuation | $30M | ||||
Revenue | |||||
Sources | 1 |
Lab21 Deal Terms
2 Deal Terms
Lab21's deal structure is available for 2 funding rounds, including their Angel - II from August 17, 2010.
Round | Angel - II | Angel |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angel - II | |||||||||||||||
Angel |
Lab21 Investors
9 Investors
Lab21 has 9 investors. Novacyt invested in Lab21's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/5/2014 | 6/5/2014 | 1 Acquired | Corporation | France | ||
Bank | United Kingdom | |||||
Angel Investor (Group) | South Carolina | |||||
Private Equity | Massachusetts | |||||
Government | South Carolina |
First funding | 6/5/2014 | ||||
|---|---|---|---|---|---|
Last Funding | 6/5/2014 | ||||
Investor | |||||
Rounds | 1 Acquired | ||||
Board Seats | |||||
Type | Corporation | Bank | Angel Investor (Group) | Private Equity | Government |
Location | France | United Kingdom | South Carolina | Massachusetts | South Carolina |
Lab21 Acquisitions
1 Acquisition
Lab21 acquired 1 company. Their latest acquisition was Selah Genomics on December 18, 2009.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/18/2009 | Debt | $0.75M | Acquired | 1 |
Date | 12/18/2009 |
|---|---|
Investment Stage | Debt |
Companies | |
Valuation | |
Total Funding | $0.75M |
Note | Acquired |
Sources | 1 |
Lab21 Portfolio Exits
2 Portfolio Exits
Lab21 has 2 portfolio exits. Their latest portfolio exit was Lab21 - Blood Bank Screening Business on October 22, 2013.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/22/2013 | Divestiture | 1 | |||
Date | 10/22/2013 | |
|---|---|---|
Exit | Divestiture | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.